Marengo Therapeutics Announces Formation of Scientific Advisory Board to Advance the Company's Development of Novel Therapeutics for Precision Immuno-Oncology
/PRNewswire/ -- Marengo Therapeutics, Inc., a company pioneering novel immuno-oncology (IO) therapeutics that directly target the Vβ chain of the T cell...